Sanofi India Future Growth

Future criteria checks 2/6

Sanofi India is forecast to grow earnings and revenue by 9.2% and 8.8% per annum respectively. EPS is expected to grow by 7.4% per annum. Return on equity is forecast to be 51.1% in 3 years.

Key information

9.2%

Earnings growth rate

7.4%

EPS growth rate

Pharmaceuticals earnings growth	18.7%
Revenue growth rate	8.8%
Future return on equity	51.1%
Analyst coverage	Low
Last updated	29 Apr 2024

Recent future growth updates

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Sanofi India Limited (NSE:SANOFI)

Dec 21

Is Sanofi India (NSE:SANOFI) A Risky Investment?

May 26

Does Sanofi India (NSE:SANOFI) Have A Healthy Balance Sheet?

May 10

Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490

Apr 02

Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490

Feb 25

Estimating The Fair Value Of Sanofi India Limited (NSE:SANOFI)

Dec 10

Earnings and Revenue Growth Forecasts

NSEI:SANOFI - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	33,986	7,231	7,856	8,482	3
12/31/2024	30,945	6,410	7,904	8,648	3
12/31/2023	28,511	6,029	1,961	2,304	N/A
9/30/2023	28,291	5,961	N/A	N/A	N/A
6/30/2023	28,064	5,751	5,090	5,411	N/A
3/31/2023	27,996	5,726	N/A	N/A	N/A
12/31/2022	27,701	6,206	3,765	3,987	N/A
9/30/2022	27,861	5,801	N/A	N/A	N/A
6/30/2022	28,487	9,790	1,447	1,633	N/A
3/31/2022	29,385	10,369	N/A	N/A	N/A
12/31/2021	29,566	9,444	5,358	5,588	N/A
9/30/2021	29,890	9,770	N/A	N/A	N/A
6/30/2021	29,211	5,801	8,106	8,294	N/A
3/31/2021	28,425	5,381	N/A	N/A	N/A
12/31/2020	29,019	4,776	5,697	6,111	N/A
9/30/2020	30,079	4,519	N/A	N/A	N/A
6/30/2020	31,004	4,456	5,127	5,765	N/A
3/31/2020	31,378	4,067	N/A	N/A	N/A
12/31/2019	30,706	4,142	3,365	4,123	N/A
9/30/2019	29,707	3,962	N/A	N/A	N/A
6/30/2019	29,354	3,888	N/A	N/A	N/A
3/31/2019	28,704	3,910	N/A	N/A	N/A
12/31/2018	27,708	3,806	3,147	3,739	N/A
9/30/2018	26,870	3,773	N/A	N/A	N/A
6/30/2018	26,107	3,744	N/A	N/A	N/A
3/31/2018	25,284	3,485	N/A	N/A	N/A
12/31/2017	24,636	3,260	3,781	4,351	N/A
9/30/2017	23,747	2,953	N/A	N/A	N/A
6/30/2017	23,454	2,619	N/A	N/A	N/A
3/31/2017	23,650	2,744	N/A	N/A	N/A
12/31/2016	23,668	3,042	N/A	3,221	N/A
9/30/2016	23,452	2,989	N/A	N/A	N/A
6/30/2016	23,068	2,909	N/A	N/A	N/A
3/31/2016	22,486	2,699	N/A	N/A	N/A
12/31/2015	21,931	2,377	N/A	2,132	N/A
9/30/2015	21,363	2,111	N/A	N/A	N/A
6/30/2015	20,654	2,005	N/A	N/A	N/A
3/31/2015	20,215	1,938	N/A	N/A	N/A
12/31/2014	19,775	1,971	N/A	2,650	N/A
9/30/2014	19,539	2,384	N/A	N/A	N/A
6/30/2014	19,364	2,534	N/A	N/A	N/A
3/31/2014	18,657	2,471	N/A	N/A	N/A
12/31/2013	18,089	2,398	N/A	2,726	N/A
9/30/2013	17,252	2,174	N/A	N/A	N/A
6/30/2013	16,493	1,916	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SANOFI's forecast earnings growth (9.2% per year) is above the savings rate (6.7%).

Earnings vs Market: SANOFI's earnings (9.2% per year) are forecast to grow slower than the Indian market (17.7% per year).

High Growth Earnings: SANOFI's earnings are forecast to grow, but not significantly.

Revenue vs Market: SANOFI's revenue (8.8% per year) is forecast to grow slower than the Indian market (10% per year).

High Growth Revenue: SANOFI's revenue (8.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SANOFI's Return on Equity is forecast to be very high in 3 years time (51.1%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Sanofi India Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target increased by 8.8% to ₹9,371

Price target increased by 12% to ₹8,392

Price target increased by 7.6% to ₹6,996

Price target decreased by 7.9% to ₹6,604

Price target decreased by 8.5% to ₹6,986

Price target decreased to ₹7,800

Recent updates

Upcoming dividend of ₹117 per share

Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00

Sanofi India Limited Announces Appointment of Flovie Martins as Head of Corporate Communications and Corporate Social Responsibility

Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00

Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director from the Board of Directors, Member of the Nomination and Remuneration Committee

Sanofi India (NSE:SANOFI) Is Due To Pay A Dividend Of ₹117.00

Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director, Member of the Nomination and Remuneration Committee

Sanofi India's (NSE:SANOFI) Dividend Will Be ₹117.00

Final dividend of ₹117 announced

Upcoming dividend of ₹50.00 per share

Price target increased by 8.8% to ₹9,371

Full year 2023 earnings released: EPS: ₹262 (vs ₹269 in FY 2022)

Sanofi India Limited, Annual General Meeting, May 14, 2024

Sanofi India Limited Recommends Final Dividend for the Financial Year Ended 31St December 2023, Payable on or After 24 May 2024

Sanofi India Limited to Report Q4, 2023 Results on Feb 23, 2024

Sanofi India Limited Appoints Radhika Shah as Head of Legal, Effective 15 January 2024

Risks To Shareholder Returns Are Elevated At These Prices For Sanofi India Limited (NSE:SANOFI)

Price target increased by 12% to ₹8,392

Third quarter 2023 earnings released: EPS: ₹65.95 (vs ₹56.84 in 3Q 2022)

Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Whole-Time Director

Sanofi India Limited to Report Q3, 2023 Results on Nov 08, 2023

Sanofi India Limited Appoints Surabhi Kaul as India People Director and Will Be Part of the Senior Management Personnel

Less than half of directors are independent

Sanofi India Limited Announces Executive Changes

Sanofi India Limited Announces Resignation of Vinita Korti Patil as Senior Legal Director - South Asia, Effective 7 December 2023

Second quarter 2023 earnings released: EPS: ₹53.37 (vs ₹52.28 in 2Q 2022)

Sanofi India Limited Announces Resignation of Gaurav Bahadur as People Director

Less than half of directors are independent

Sanofi India Limited to Report Q2, 2023 Results on Aug 10, 2023

Sanofi India Limited Announces Resignation of Annapurna Das as Non-Executive Director and Member of the Audit Committee, Effective 31 July 2023

Is Sanofi India (NSE:SANOFI) A Risky Investment?

Price target increased by 7.6% to ₹6,996

Full year 2022 earnings released: EPS: ₹269 (vs ₹410 in FY 2021)

Price target decreased by 7.9% to ₹6,604

Price target decreased by 8.5% to ₹6,986

Sanofi India Limited to Report Q4, 2022 Results on Feb 23, 2023

High number of new directors

Third quarter 2022 earnings released: EPS: ₹56.84 (vs ₹230 in 3Q 2021)

Sanofi India Limited Announces Change in Directorate

Sanofi India Limited to Report Q3, 2022 Results on Nov 03, 2022

Upcoming dividend of ₹193 per share

Price target decreased to ₹7,800

Second quarter 2022 earnings released: EPS: ₹52.28 (vs ₹77.42 in 2Q 2021)

Sanofi India Limited Approves One-Time Special Interim Dividend, Payable on August 22, 2022

Sanofi India Limited to Report Q2, 2022 Results on Jul 26, 2022

Does Sanofi India (NSE:SANOFI) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: EPS: ₹104 (vs ₹63.35 in 1Q 2021)

Less than half of directors are independent

Sanofi India Appoints Rodolfo Hrosz as Managing Director

Sanofi India Limited to Report Q1, 2022 Results on Apr 26, 2022

Upcoming dividend of ₹490 per share

Full year 2021 earnings released: EPS: ₹410 (vs ₹207 in FY 2020)

Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490

Sanofi India Limited Proposes Final Dividend for the Financial Year Ended December 31, 2021, Payable on or After May 4, 2022

Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490

Sanofi India Limited, Annual General Meeting, Apr 26, 2022

Sanofi India Limited Approves Final Dividend for the Year Ended 31 December 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Sanofi India Limited to Report Q4, 2021 Results on Feb 23, 2022

Estimating The Fair Value Of Sanofi India Limited (NSE:SANOFI)

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company

Non-Executive Director Cyril Grandchamp-Desraux has left the company